UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: CitodonEv-500mg30mg-Tablet-SE-IS-MPD-BBDL

Citodon® 500 mg/30 mg Tablett

MPID: SE-100002766-0009777
EURDID: 851

Full name: Citodon® 500 mg/30 mg Tablett

- Invented name part: Citodon®

- Strength part: 500 mg/30 mg

- Pharmaceutical dose form part: Tablett

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Tablet

Legal status of supply: Medicinal product subject to special medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000093533 N02AJ06

Marketing Authorisation 1 of 1

Authorisation number: 9777

Region: Kingdom of Sweden

Marketing authorisation holder: Evolan Pharma AB

Identifier:

  • LOC-100016200

Status: Valid (1982-03-12)

Package 1 of 5

PCID:

Description:
Blister, 10 tabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 10 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 1 Blister (Aluminium) (PolyVinyl Chloride)

Containing: 10 Tablet

Manufactured Item

Dose form: Tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Paracetamol DC

Concentration strength: 520 milligram(s) / 1 unit(s)

Reference strength:
Paracetamol 500 milligram(s) / 1 unit(s)

Ingredient

Role: Active

Substance: Codeine phosphate hemihydrate

Concentration strength: 30 milligram(s) / 1 unit(s)

Reference strength:
Codeine anhydrous 22.1 milligram(s) / 1 unit(s)

Package 2 of 5

PCID:

Description:
Blister, 100 tabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 100 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 10 Blister (Aluminium) (PolyVinyl Chloride)

Containing: 10 Tablet

Manufactured Item

Dose form: Tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Paracetamol DC

Concentration strength: 520 milligram(s) / 1 unit(s)

Reference strength:
Paracetamol 500 milligram(s) / 1 unit(s)

Ingredient

Role: Active

Substance: Codeine phosphate hemihydrate

Concentration strength: 30 milligram(s) / 1 unit(s)

Reference strength:
Codeine anhydrous 22.1 milligram(s) / 1 unit(s)

Package 3 of 5

PCID:

Description:
Blister, 20 tabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 10 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 2 Blister (Aluminium) (PolyVinyl Chloride)

Containing: 10 Tablet

Manufactured Item

Dose form: Tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Paracetamol DC

Concentration strength: 520 milligram(s) / 1 unit(s)

Reference strength:
Paracetamol 500 milligram(s) / 1 unit(s)

Ingredient

Role: Active

Substance: Codeine phosphate hemihydrate

Concentration strength: 30 milligram(s) / 1 unit(s)

Reference strength:
Codeine anhydrous 22.1 milligram(s) / 1 unit(s)

Package 4 of 5

PCID:

Description:
Burk, 100 tabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 100 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 1 Bottle (Plastic)

Containing: 100 Tablet

Manufactured Item

Dose form: Tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Paracetamol DC

Concentration strength: 520 milligram(s) / 1 unit(s)

Reference strength:
Paracetamol 500 milligram(s) / 1 unit(s)

Ingredient

Role: Active

Substance: Codeine phosphate hemihydrate

Concentration strength: 30 milligram(s) / 1 unit(s)

Reference strength:
Codeine anhydrous 22.1 milligram(s) / 1 unit(s)

Package 5 of 5

PCID:

Description:
Blister, 50 tabletter

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 10 Tablet

Package: 1 Box (Cardboard)

Containing:

Package: 5 Blister (Aluminium) (PolyVinyl Chloride)

Containing: 10 Tablet

Manufactured Item

Dose form: Tablet

Unit of presentation: Tablet

Ingredient

Role: Active

Substance: Paracetamol DC

Concentration strength: 520 milligram(s) / 1 unit(s)

Reference strength:
Paracetamol 500 milligram(s) / 1 unit(s)

Ingredient

Role: Active

Substance: Codeine phosphate hemihydrate

Concentration strength: 30 milligram(s) / 1 unit(s)

Reference strength:
Codeine anhydrous 22.1 milligram(s) / 1 unit(s)

Administrable Product (1 of 1)

Dose form: Tablet

Unit of presentation:

Route of administration:

  • Oral use

Ingredients:

Ingredient

Role: Active

Substance: Paracetamol DC

Concentration strength: 520 milligram(s) / 1 unit(s)

Reference strength:
Paracetamol 500 milligram(s) / 1 unit(s)

Ingredient

Role: Active

Substance: Codeine phosphate hemihydrate

Concentration strength: 30 milligram(s) / 1 unit(s)

Reference strength:
Codeine anhydrous 22.1 milligram(s) / 1 unit(s)